Dr Jessica Vanslambrouck
Dr Jessica Vanslambrouck
Details
Role
Team Leader / Senior Research Fellow
Research area
Stem Cell Medicine
Group
Kidney Regeneration
Contact
Available for student supervision
Dr Jessica Vanslambrouck is a Team Leader in the Kidney Regeneration group at the Murdoch Children’s Research Institute (MCRI) and an Associate Investigator with the Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, where her work focuses on stem cell approaches to improve kidney disease outcomes.
Dr Vanslambrouck’s research has pioneered patented approaches for creating progenitors and kidney organoids using cellular reprogramming, stem cell differentiation, and 3D cellular bioprinting bioprinting (Nature Cell Biology 2014, Kidney International 2019, Nature Materials 2021). Having recently developed methodology to improve the accuracy and functionality of proximal tubules within stem cell-derived kidney tissue (Nature Comms 2022, Nature Protocols 2023), Dr Vanslambrouck is building on these innovations to create sustainable bioengineered kidney tissue applicable to therapeutic approaches such as bioartificial device development.
As a University of Melbourne Honorary Fellow and Chair of the Sponsorship and Industry Subcommittee for The Australasian Society for Stem Cell Research (ASSCR), Dr Vanslambrouck is a passionate advocate for Australian stem cell research and fostering the development of emerging scientists.
Dr Vanslambrouck’s research has pioneered patented approaches for creating progenitors and kidney organoids using cellular reprogramming, stem cell differentiation, and 3D cellular bioprinting bioprinting (Nature Cell Biology 2014, Kidney International 2019, Nature Materials 2021). Having recently developed methodology to improve the accuracy and functionality of proximal tubules within stem cell-derived kidney tissue (Nature Comms 2022, Nature Protocols 2023), Dr Vanslambrouck is building on these innovations to create sustainable bioengineered kidney tissue applicable to therapeutic approaches such as bioartificial device development.
As a University of Melbourne Honorary Fellow and Chair of the Sponsorship and Industry Subcommittee for The Australasian Society for Stem Cell Research (ASSCR), Dr Vanslambrouck is a passionate advocate for Australian stem cell research and fostering the development of emerging scientists.
Dr Jessica Vanslambrouck is a Team Leader in the Kidney Regeneration group at the Murdoch Children’s Research Institute (MCRI) and an Associate Investigator with the Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, where her work...
Dr Jessica Vanslambrouck is a Team Leader in the Kidney Regeneration group at the Murdoch Children’s Research Institute (MCRI) and an Associate Investigator with the Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, where her work focuses on stem cell approaches to improve kidney disease outcomes.
Dr Vanslambrouck’s research has pioneered patented approaches for creating progenitors and kidney organoids using cellular reprogramming, stem cell differentiation, and 3D cellular bioprinting bioprinting (Nature Cell Biology 2014, Kidney International 2019, Nature Materials 2021). Having recently developed methodology to improve the accuracy and functionality of proximal tubules within stem cell-derived kidney tissue (Nature Comms 2022, Nature Protocols 2023), Dr Vanslambrouck is building on these innovations to create sustainable bioengineered kidney tissue applicable to therapeutic approaches such as bioartificial device development.
As a University of Melbourne Honorary Fellow and Chair of the Sponsorship and Industry Subcommittee for The Australasian Society for Stem Cell Research (ASSCR), Dr Vanslambrouck is a passionate advocate for Australian stem cell research and fostering the development of emerging scientists.
Dr Vanslambrouck’s research has pioneered patented approaches for creating progenitors and kidney organoids using cellular reprogramming, stem cell differentiation, and 3D cellular bioprinting bioprinting (Nature Cell Biology 2014, Kidney International 2019, Nature Materials 2021). Having recently developed methodology to improve the accuracy and functionality of proximal tubules within stem cell-derived kidney tissue (Nature Comms 2022, Nature Protocols 2023), Dr Vanslambrouck is building on these innovations to create sustainable bioengineered kidney tissue applicable to therapeutic approaches such as bioartificial device development.
As a University of Melbourne Honorary Fellow and Chair of the Sponsorship and Industry Subcommittee for The Australasian Society for Stem Cell Research (ASSCR), Dr Vanslambrouck is a passionate advocate for Australian stem cell research and fostering the development of emerging scientists.
Top Publications
- Kairath, P, Er, PX, Wilson, S, Ghobrial, I, Vanslambrouck, JM, Chen, Y-H, Pruett-Miller, SM, Jain, S, Little, MH. In vitro plasticity between ureteric epithelial and distal nephron identity and maturity is controlled by extracellular signals.. Dev Biol 533: 75 -88 2026 view publication
- Wilson, SB, Vanslambrouck, JM, Murphy, A, Neavin, DR, Powell, JE, Howden, SE, Little, MH. Classification of indeterminate and off-target cell types within human kidney organoid differentiation. 2026 view publication
- Vanslambrouck, JM, Tan, KS, Mah, S, Little, MH. Author Correction: Generation of proximal tubule-enhanced kidney organoids from human pluripotent stem cells.. Nat Protoc 2025 view publication
- Kairath, P, Er, PX, Wilson, S, Ghobrial, I, Vanslambrouck, JM, Yi-Hsien, C, Pruett-Miller, SM, Jain, S, Little, MH. In vitro plasticity between ureteric epithelial and distal nephron identity and maturity is controlled by extracellular signals.. 2025 view publication
- Lindström, NO, Vanslambrouck, JM. Patterning the nephron: Forming an axial polarity with distal and proximal specialization.. 163: 83 -103 2025 view publication
Page 1 of 8
Career information
Share //
